SCHEMBL13638555

SCHEMBL13638555

CNc1cc2c(cc1Cl)C(=O)N(c1ccc(NC(=O)NS(=O)(=O)c3ccc(C)s3)cn1)C(=O)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 7/20 0.38
FBP1 P09467 1/20 0.34
GRM1 Q13255 3/20 0.34
GRM4 Q14833 1/20 0.34
CA12 O43570 5/20 0.33
CA1 P00915 5/20 0.33
CA9 Q16790 5/20 0.33
CA2 P00918 4/20 0.33
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
NLRP3 Q96P20 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
CA14 Q9ULX7 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922613 0.94 P2RY12 (0.43) P2RY12FBP1GRM1GRM4CA12
SCHEMBL12161612 0.92 P2RY12 (0.40) P2RY12FBP1GRM1GRM4CA12
SCHEMBL13638556 0.91 P2RY12 (0.35) P2RY12FBP1GRM1CA12CA1
SCHEMBL9922617 0.86 FBP1 (0.43) P2RY12FBP1CA12CA1CA9
SCHEMBL14228632 0.86 P2RY12 (0.42) P2RY12FBP1CA12CA1CA9
SCHEMBL14113602 0.86 BRD4 (0.35) P2RY12FBP1GRM1GRM4CA12
SCHEMBL12177057 0.85 P2RY12 (0.42) P2RY12GRM1GRM4BRD4CREBBP
SCHEMBL13638496 0.84 FBP1 (0.41) FBP1GRM1BRD4CREBBPNLRP3
SCHEMBL9922821 0.83 FBP1 (0.42) P2RY12FBP1MEN1KMT2A
SCHEMBL9923230 0.83 P2RY12 (0.37) P2RY12FBP1GRM1GRM4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed